These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hemochromatosis. Determination of the C282Y mutation frequency in the population of the Czech Republic and sensitivity of hemochromatosis detection using Guthrie cards]. Zdárský E; Horák J; Stríteský J; Heirler F Cas Lek Cesk; 1999 Aug; 138(16):497-9. PubMed ID: 10566227 [TBL] [Abstract][Full Text] [Related]
3. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda]. Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743 [TBL] [Abstract][Full Text] [Related]
4. The frequency of the haemochromatosis C282Y mutation in the ethnic Hungarian and Romany populations of eastern Hungary. Szakony S; Balogh I; Muszbek L Br J Haematol; 1999 Nov; 107(2):464-5. PubMed ID: 10583244 [No Abstract] [Full Text] [Related]
5. You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation. Piippo K; Louhija J; Tilvis R; Kontula K Eur J Clin Invest; 2003 Sep; 33(9):830-1. PubMed ID: 12925044 [No Abstract] [Full Text] [Related]
6. Haemochromatosis and type 2 diabetes. Aldersley MA; Allgar V; Howdle PD; Markham AF Lancet; 1998 Sep; 352(9133):1067-8. PubMed ID: 9759782 [No Abstract] [Full Text] [Related]
7. Molecular diagnosis of hereditary haemochromatosis--identify an affected person and save a family. Milani MY; Kotze MJ S Afr Med J; 1999 Mar; 89(3):263-4. PubMed ID: 10226670 [No Abstract] [Full Text] [Related]
8. Clinical haemochromatosis in HFE mutation carriers. Allen KJ; Warner B; Delatycki MB Lancet; 2002 Aug; 360(9330):412-3; author reply 413-4. PubMed ID: 12241805 [No Abstract] [Full Text] [Related]
9. The C282Y mutation does not shorten life span. Beutler E; Felitti VJ Arch Intern Med; 2002 May; 162(10):1196-7. PubMed ID: 12020197 [No Abstract] [Full Text] [Related]
10. Deaths attributed to haemochromatosis are rare in Britain. Willis G; Fellows IW; Wimperis JZ BMJ; 2000 Apr; 320(7242):1146. PubMed ID: 10775237 [No Abstract] [Full Text] [Related]
11. [Digestive disorders: improving the accuracy and safety of tests]. Bonnaud G Presse Med; 1998 May; 27(18):869-70. PubMed ID: 9767877 [No Abstract] [Full Text] [Related]
12. Cracking genetic codes of longevity. Wang MC Nat Rev Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34312517 [No Abstract] [Full Text] [Related]
13. Longevity and C282Y mutation for haemochromatosis: survival of C282Y homozygotes does not preclude screening for HFE mutations. Willis G; Jennings BA; Wimperis JZ BMJ; 2003 Oct; 327(7421):990-1; author reply 991. PubMed ID: 14576264 [No Abstract] [Full Text] [Related]
14. Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians. Coppin H; Bensaid M; Fruchon S; Borot N; Blanché H; Roth MP BMJ; 2003 Jul; 327(7407):132-3. PubMed ID: 12869454 [No Abstract] [Full Text] [Related]
15. Longevity and C282Y mutation for haemochromatosis: data do not support conclusion. Li AC; Powell J BMJ; 2003 Oct; 327(7421):990; author reply 991. PubMed ID: 14576265 [No Abstract] [Full Text] [Related]
16. Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutation. Brown K; Luddington R; Taylor SA; Lillicrap DP; Baglin TP Br J Haematol; 1999 Apr; 105(1):95-7. PubMed ID: 10233369 [TBL] [Abstract][Full Text] [Related]